← FDA DRUG APPROVALS

FDA ANDA · ANDA040177

TRIHEXYPHENIDYL HYDROCHLORIDE

Sponsor: PHARM ASSOC

APPLICATION
ANDA040177
TYPE
ANDA
ORIGINAL APPROVAL
1997-04-17
LATEST ACTION
2011-06-30
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Prescription

Products

TRIHEXYPHENIDYL HYDROCHLORIDEPrescription
TRIHEXYPHENIDYL HYDROCHLORIDE 2MG/5ML · ELIXIR · ORAL

Approval history

2011-06-30Labeling · Supplement 3AP
2010-10-04Labeling · Supplement 2AP
1997-04-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →